XML 31 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows:

September 30, 2021

December 31, 2020

September 30, 2020

December 31, 2019

Cash and cash equivalents

$

25,352,337

$

13,360,463

$

10,488,072

$

2,708,223

Restricted cash

549,730

746,792

293,972

185,380

Total cash and cash equivalents and restricted cash in the condensed consolidated statements of cash flows

$

25,902,067

$

14,107,255

$

10,782,044

$

2,893,603

Schedule of Inventories

Inventories are valued using the first-in, first-out method and stated at the lower of cost or net realizable value and consist of the following:

September 30, 2021

December 31, 2020

Raw materials and supplies

$

850,402

$

773,021

Work-in-process

58,217

87,159

Finished goods

3,423,285

2,312,148

Total

$

4,331,904

$

3,172,328

Schedule of Finite-Lived Intangible Assets

Intangible assets include trademarks, developed technology, In-Process Research & Development, software and customer relationships and consisted of the following as of September 30, 2021 and December 31, 2020:

September 30, 2021

December 31, 2020

Subsidiary

Cost

Accumulated

Amortization

Effect of

Foreign

Exchange

Rates

Net Balance

Accumulated

Amortization

Impairment

Effect of

Foreign

Exchange

Rates

Net Balance

Trademarks and tradenames

 

AdvanDx

$

461,000

$

$

$

$

(217,413

)

$

(243,587

)

$

$

Developed technology

AdvanDx

 

458,000

 

 

 

 

 

 

 

 

(308,526

)

 

(149,474

)

 

 

Customer relationships

AdvanDx

1,094,000

(736,465

)

(357,535

)

Trademarks and tradenames

Curetis

1,768,000

(277,723

)

83,469

1,573,746

(147,161

)

194,119

1,814,958

Distributor relationships

Curetis

2,362,000

(247,356

)

111,511

2,226,155

(131,070

)

259,336

2,490,266

A50 - Developed technology

Curetis

349,000

(78,326

)

16,477

287,151

(41,504

)

38,319

345,815

Ares - Developed technology

Curetis

5,333,000

(598,360

)

251,772

4,986,412

(317,060

)

585,536

5,601,476

A30 - In-Process Research & Development

Curetis

5,706,000

270,923

5,976,923

622,448

6,328,448

$

17,531,000

$

(1,201,765

)

$

734,152

$

15,050,387

$

(1,899,199

)

$

(750,596

)

$

1,699,758

$

16,580,963

Schedule of Estimated Useful Lives of Identifiable Intangible Assets

Identifiable intangible assets will be amortized on a straight-line basis over their estimated useful lives. The estimated useful lives of the intangibles are:

Estimated Useful Life

Trademarks and tradenames

10 years

Customer/distributor relationships

15 years

A50 – Developed technology

7 years

Ares – Developed technology

14 years

A30 – Acquired in-process research & development

Indefinite

Schedule of Expected Amortization of Intangible Assets

Total amortization expense of intangible assets was $212,829 and $205,026 for the three months ended September 30, 2021 and 2020, respectively. Total amortization expense of intangible assets was $615,471 and $464,689 for the nine months ended September 30, 2021 and 2020, respectively. Expected future amortization of intangible assets is as follows:

Year Ending December 31,

 

2021 (Three months)

$

200,294

2022

801,174

2023

801,174

2024

801,174

2025

801,174

2026

801,174

Thereafter

4,867,300

Total

$

9,073,464

Schedule of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill as of September 30, 2021, and since December 31, 2020, were as follows:

Balance as of December 31, 2020

 

$

8,024,729

Changes in currency translation

(418,658

)

Balance as of September 30, 2021

$

7,606,071